Duration of treatment of problematic infantile hemangioma with oral propranolol: a single institutional review
Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2018, Vol 17, Issue 12
Abstract
Aims: To study the use of propranolol as a single therapy in problematic infantile hemangioma with special reference to the total duration of treatment and its short term outcome(s). Methods: Single institutional retrospective study of patients of problematic infantile hemangioma treated with propranolol between January 2016 to December 2017. Assessment was done by change in colour , redness & size. Accordingly, outcome was graded as excellent, good/partial and no response. Results: 17 girls and 9 boys with problematic infantile hemangioma were initiated treatment with propranolol at the mean age of 7 months(range 2-24 months) for a mean duration of 12 months(range 6-18 months). Head and neck was the most common site(65%). Complete/excellent response was seen in 16 patients(61.6%), good/partial response in 8(30.7%) and no response in 2 patients(7.7%). Rebound was seen in 3 patients(12%). Conclusions: Use of oral propranolol in problematic infantile hemangioma is safe, feasible and effective with very few adverse effects at the recommended dosage of 2-3 mg/kg/day in divided dosage. Treatment should continue till the complete regression of the lesion for at least 12 months substantiated by the fact that all the 3 cases of rebound had received treatment for lesser duration and showed excellent response to longer duration of treatment.
Authors and Affiliations
Sujay Kumar Maitra, Sukanta Kumar Das, Rajarshi Kumar
Keywords
Related Articles
- EP ID EP423834
- DOI 10.9790/0853-1712055859.
- Views 39
- Downloads 0
Estimation of the Level of (25) Hydroxy Vitamin D in Elderly Patients with Chronic Obstructive Pulmonary Disease
Introduction: Chronic obstructive pulmonary disease (COPD) is characterized by airflow obstruction that is not fully reversible. The airflow limitation is usually progressive and is associated with an abnormal inflammato...
Comparative Study of Tadalafil And Tamsulosin in Benign Hyperplasia of Prostate For Lower Urinary Tract Symptoms (LUTS)
Objectives: Tadalafil has been approved by the U.S. Food and Drug Administration in 2011 to treat the signs and symptoms of Lower Urinary Tract symptoms (LUTS) due to benign hyperplasia of prostate(BHP). Tamsulosin is be...
Immunoglobulin G4-Related Orbital Disease With Asymmetrical Orbital Infiltration In A 65 Years Old Male – A Case Report.
Immunoglobulin G4-related disease is a systemic disease in which there is infiltration of multiple organ tissues by IgG4+ plasma cells resulting fibro-inflammatory lesion. In the region ofthehead, the disease affects the...
Comparative Evaluation of Efficacy, Hemodynamic Stability and Recovery during Conscious Sedation with Dexmedetomidine or Propofol in Cardiac Catheterization Laboratory
Background:Conscious sedation provides calm and cooperative patient for interventional procedures. We compared dexmedetomidineand propofolin combination with fentanylfor conscious sedation during cardiac catheterization...
Ocular Manifestations in Multi-Transfused Beta-Thalassemia Patients
Introduction: Ocular abnormalities are unseen morbidity due to iron overload in thalassemia patients which is being brought into light by our study. Aim & objectives: To study the ocular manifestations in transfusion dep...